- Global Surgery: Accurately Report Postoperative Visits
A recent HHS Office of Inspector General review found that the number of postoperative visits included in Medicare’s global surgery fee valuations is generally higher than the number of visits actually provided, highlighting the importance of accurately reporting postoperative visits when required. CMS provides guidance on reporting these visits in both inpatient and outpatient settings.
- HCPCS Application Summaries & Coding Determinations: Drugs & Biologicals
CMS has released its 2026 Quarter 2 HCPCS Level II Application Summary and Coding Determinations for drugs and biological products, providing the agency’s decisions on submitted coding requests; practices can review the full determinations through CMS’ HCPCS Level II Coding Decisions resources.
Resource: MLN Connects® Newsletter